Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review.

Bonde JH, Sandri MT, Gary DS, Andrews JC.

J Low Genit Tract Dis. 2019 Nov 8. doi: 10.1097/LGT.0000000000000494. [Epub ahead of print]

PMID:
31714325
2.

Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project.

Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, Fasulo V, Paciotti M, Domanico L, Bevilacqua G, Maffei D, Diana P, Frego N, Sandri MT, Maura F, Morenghi E, Buffi NM, Guazzoni G, Lazzeri M.

World J Urol. 2019 Nov 5. doi: 10.1007/s00345-019-03002-3. [Epub ahead of print]

PMID:
31691083
3.

Distribution of High-Risk Human Papillomavirus Genotypes and Multiple Infections in Preneoplastic and Neoplastic Cervical Lesions of Unvaccinated Women: A Cross-sectional Study.

Iacobone AD, Bottari F, Radice D, Preti EP, Franchi D, Vidal Urbinati AM, Boveri S, Passerini R, Sandri MT.

J Low Genit Tract Dis. 2019 Oct;23(4):259-264. doi: 10.1097/LGT.0000000000000487.

PMID:
31592973
4.

Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Systematic Review.

Bottari F, Iacobone AD, Passerini R, Preti EP, Sandri MT, Cocuzza CE, Gary DS, Andrews JC.

Obstet Gynecol. 2019 Sep;134(3):452-462. doi: 10.1097/AOG.0000000000003409.

5.

Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Cosentino N, Campodonico J, Pontone G, Guglielmo M, Trinei M, Sandri MT, Riggio D, Baggiano A, Milazzo V, Moltrasio M, Muscogiuri G, Bonomi A, Barbieri S, Assanelli E, Lauri G, Bartorelli A, Marenzi G.

Int J Cardiol. 2019 Jul 31. pii: S0167-5273(19)32614-2. doi: 10.1016/j.ijcard.2019.07.083. [Epub ahead of print]

PMID:
31399299
6.

New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1.

Mauro C, Passerini R, Spaggiari L, Galetta D, Radice D, Lentati P, Sandri MT.

Int J Biol Markers. 2019 Jun;34(2):163-167. doi: 10.1177/1724600819834235. Epub 2019 Apr 17.

PMID:
30994045
7.

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort.

Bonde J, Bottari F, Parvu V, Pedersen H, Yanson K, Iacobone AD, Kodsi S, Landoni F, Vaughan L, Ejegod DM, Sandri MT.

Int J Cancer. 2019 Aug 15;145(4):1033-1041. doi: 10.1002/ijc.32291. Epub 2019 Apr 30.

8.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.

Cristofanilli M, Pierga JY, Reuben J, Rademaker A, Davis AA, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Giuliano M, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Cabel L, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Generali D, Cappelletti MR, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Darrigues L, Reis-Filho JS, Gerratana L, Michiels S, Bidard FC, Pantel K.

Crit Rev Oncol Hematol. 2019 Feb;134:39-45. doi: 10.1016/j.critrevonc.2018.12.004. Epub 2018 Dec 19. Review.

PMID:
30771872
9.

Improvement of neutrophil gelatinase-associated lipocalin sensitivity and specificity by two plasma measurements in predicting acute kidney injury after cardiac surgery.

Introcaso G, Nafi M, Bonomi A, L'Acqua C, Salvi L, Ceriani R, Carcione D, Cattaneo A, Sandri MT.

Biochem Med (Zagreb). 2018 Oct 15;28(3):030701. doi: 10.11613/BM.2018.030701.

10.

Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.

Ferro M, Musi G, Serino A, Cozzi G, Mistretta FA, Costa B, Bianchi R, Cordima G, Luzzago S, Di Trapani E, Tagliabue E, Vartolomei MD, Terracciano D, Cassatella MC, Salvatici M, Conti A, Sandri MT, Cioffi A, Turetti M, Catellani M, Bottero D, Matei DV, Mirone V, de Cobelli O.

Urol Int. 2019;102(1):43-50. doi: 10.1159/000494259. Epub 2018 Nov 8.

PMID:
30408799
11.

Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions.

Bottari F, Iacobone AD, Boveri S, Preti EP, Franchi D, Mariani L, Preti M, Landoni F, Passerini R, Sandri MT.

J Low Genit Tract Dis. 2019 Jan;23(1):39-42. doi: 10.1097/LGT.0000000000000441.

PMID:
30371554
12.

Acute kidney injury after lung cancer surgery: Incidence and clinical relevance, predictors, and role of N-terminal pro B-type natriuretic peptide.

Cardinale D, Cosentino N, Moltrasio M, Sandri MT, Petrella F, Colombo A, Bacchiani G, Tessitore A, Bonomi A, Veglia F, Salvatici M, Cipolla CM, Marenzi G, Spaggiari L.

Lung Cancer. 2018 Sep;123:155-159. doi: 10.1016/j.lungcan.2018.07.009. Epub 2018 Jul 17.

PMID:
30089588
13.

ST2 and B-type natriuretic peptide kinetics during exercise in severe heart failure.

Magini A, Farina S, Riggio D, Sandri MT, Agostoni P.

Eur J Heart Fail. 2018 Oct;20(10):1494-1495. doi: 10.1002/ejhf.1246. Epub 2018 Jul 27. No abstract available.

14.

Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial.

Cardinale D, Ciceri F, Latini R, Franzosi MG, Sandri MT, Civelli M, Cucchi G, Menatti E, Mangiavacchi M, Cavina R, Barbieri E, Gori S, Colombo A, Curigliano G, Salvatici M, Rizzo A, Ghisoni F, Bianchi A, Falci C, Aquilina M, Rocca A, Monopoli A, Milandri C, Rossetti G, Bregni M, Sicuro M, Malossi A, Nassiacos D, Verusio C, Giordano M, Staszewsky L, Barlera S, Nicolis EB, Magnoli M, Masson S, Cipolla CM; ICOS-ONE Study Investigators.

Eur J Cancer. 2018 May;94:126-137. doi: 10.1016/j.ejca.2018.02.005. Epub 2018 Mar 20.

PMID:
29567630
15.

Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+ in two time periods.

Bottari F, Boveri S, Iacobone AD, Gulmini C, Igidbashian S, Cassatella MC, Landoni F, Sandri MT.

Infect Dis (Lond). 2018 Jul;50(7):554-559. doi: 10.1080/23744235.2018.1441538. Epub 2018 Feb 20.

PMID:
29463149
16.

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples.

Ejegod DM, Junge J, Franzmann M, Kirschner B, Bottari F, Sideri M, Sandri MT, Bonde J.

Papillomavirus Res. 2016 Dec;2:31-37. doi: 10.1016/j.pvr.2016.01.003. Epub 2016 Mar 2.

17.

MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy.

Sommariva E, D'Alessandra Y, Farina FM, Casella M, Cattaneo F, Catto V, Chiesa M, Stadiotti I, Brambilla S, Dello Russo A, Carbucicchio C, Vettor G, Riggio D, Sandri MT, Barbuti A, Vernillo G, Muratori M, Dal Ferro M, Sinagra G, Moimas S, Giacca M, Colombo GI, Pompilio G, Tondo C.

Sci Rep. 2017 Jul 6;7(1):4802. doi: 10.1038/s41598-017-05001-z.

18.

The clinical implementation of primary HPV screening.

Mariani L, Igidbashian S, Sandri MT, Vici P, Landoni F.

Int J Gynaecol Obstet. 2017 Mar;136(3):266-271. doi: 10.1002/ijgo.12065. Epub 2017 Jan 3. Review.

PMID:
28099686
19.

Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.

Cardinale D, Biasillo G, Salvatici M, Sandri MT, Cipolla CM.

Expert Rev Mol Diagn. 2017 Mar;17(3):245-256. doi: 10.1080/14737159.2017.1283219. Epub 2017 Jan 29. Review.

PMID:
28092472
20.

Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.

Giorgi Rossi P, Carozzi F, Federici A, Ronco G, Zappa M, Franceschi S; Italian Screening in HPV vaccinated girls Consensus Conference group.

Prev Med. 2017 May;98:21-30. doi: 10.1016/j.ypmed.2016.11.020. Epub 2016 Nov 25.

21.

Diagnostic and Prognostic Utility of Circulating Cytochrome c in Acute Myocardial Infarction.

Marenzi G, Cosentino N, Boeddinghaus J, Trinei M, Giorgio M, Milazzo V, Moltrasio M, Cardinale D, Sandri MT, Veglia F, Bonomi A, Kaech M, Twerenbold R, Nestelberger T, Reichlin T, Wildi K, Shrestha S, Kohzuharov N, Sabti Z, Cipolla CM, Mueller C, Bartorelli AL.

Circ Res. 2016 Dec 9;119(12):1339-1346. Epub 2016 Oct 31.

22.

Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity.

Bianchi S, Boveri S, Igidbashian S, Amendola A, Urbinati AM, Frati ER, Bottari F, Colzani D, Landoni F, Tanzi E, Sideri M, Sandri MT.

Arch Gynecol Obstet. 2016 Nov;294(6):1227-1233. Epub 2016 Aug 8.

PMID:
27501926
23.

Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine.

Igidbashian S, Boveri S, Bottari F, Vidal Urbinati A, Preti E, Casadio C, Landoni F, Sideri M, Sandri MT.

J Low Genit Tract Dis. 2017 Jan;21(1):4-8. doi: 10.1097/LGT.0000000000000268.

PMID:
27755229
24.

HPV self-sampling in CIN2+ detection: sensitivity and specificity of different RLU cut-off of HC2 in specimens from 786 women.

Bottari F, Igidbashian S, Boveri S, Tricca A, Gulmini C, Sesia M, Spolti N, Sideri M, Landoni F, Sandri MT.

J Clin Pathol. 2017 Apr;70(4):327-330. doi: 10.1136/jclinpath-2016-204044. Epub 2016 Sep 26.

PMID:
27672216
25.

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.

Ejegod D, Bottari F, Pedersen H, Sandri MT, Bonde J.

J Clin Microbiol. 2016 Sep;54(9):2267-72. doi: 10.1128/JCM.00508-16. Epub 2016 Jun 15.

26.

Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.

Aurilio G, Sandri MT, Pruneri G, Zorzino L, Botteri E, Munzone E, Adamoli L, Facchi G, Cullurà D, Verri E, Rocca MC, Zurrida S, Iacovelli R, Nolè F.

Future Oncol. 2016 Sep;12(17):2001-8. doi: 10.2217/fon-2016-0081. Epub 2016 Jun 3.

PMID:
27255717
27.

Optimization and Standardization of Circulating MicroRNA Detection for Clinical Application: The miR-Test Case.

Marzi MJ, Montani F, Carletti RM, Dezi F, Dama E, Bonizzi G, Sandri MT, Rampinelli C, Bellomi M, Maisonneuve P, Spaggiari L, Veronesi G, Bianchi F, Di Fiore PP, Nicassio F.

Clin Chem. 2016 May;62(5):743-54. doi: 10.1373/clinchem.2015.251942.

28.

Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.

Salvatici M, Achilarre MT, Sandri MT, Boveri S, Vanna Z, Landoni F.

Gynecol Oncol. 2016 Jul;142(1):115-119. doi: 10.1016/j.ygyno.2016.04.029. Epub 2016 May 6.

PMID:
27117922
29.

B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis.

Lauri G, Rossi C, Rubino M, Cosentino N, Milazzo V, Marana I, Cabiati A, Moltrasio M, De Metrio M, Grazi M, Campodonico J, Assanelli E, Riggio D, Sandri MT, Bonomi A, Veglia F, Marenzi G.

Int J Cardiol. 2016 Jun 1;212:318-23. doi: 10.1016/j.ijcard.2016.03.075. Epub 2016 Mar 22.

PMID:
27057950
30.

Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial.

Cardinale D, Sandri MT, Colombo A, Salvatici M, Tedeschi I, Bacchiani G, Beggiato M, Meroni CA, Civelli M, Lamantia G, Colombo N, Veglia F, Casiraghi M, Spaggiari L, Venturino M, Cipolla CM.

Ann Surg. 2016 Aug;264(2):244-51. doi: 10.1097/SLA.0000000000001626.

PMID:
26764872
31.

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions.

Mariani L, Sandri MT, Preti M, Origoni M, Costa S, Cristoforoni P, Bottari F, Sideri M.

J Cancer. 2016 Jan 1;7(1):107-14. doi: 10.7150/jca.13503. eCollection 2016. Review.

32.

Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study.

Balduzzi A, Bagnardi V, Sandri MT, Dellapasqua S, Cardillo A, Montagna E, Cancello G, Iorfida M, Ghisini R, Viale G, Intra M, Luini A, Goldhirsch A, Colleoni M.

Clin Breast Cancer. 2015 Oct;15(5):e257-62. doi: 10.1016/j.clbc.2015.03.007. Epub 2015 Apr 30.

PMID:
26362840
33.

The predictive value of human papillomavirus testing for the outcome of patients conservatively treated for stage IA squamous cell cervical carcinoma.

Costa S, Sideri M, Negri G, Venturoli S, Santini D, Casadio C, Sandri MT, Bucchi L.

J Clin Virol. 2015 Sep;70:53-57. doi: 10.1016/j.jcv.2015.07.007. Epub 2015 Jul 8.

PMID:
26305820
34.

Identifying cancer patients at risk for cardiotoxicity.

Salvatici M, Sandri MT.

Future Oncol. 2015;11(14):2077-91. doi: 10.2217/fon.15.69. Review.

PMID:
26198838
35.

Cardio-oncology: a special focus issue from Future Oncology.

Jones RL, Sandri MT.

Future Oncol. 2015;11(14):1993-4. doi: 10.2217/fon.15.126. No abstract available.

36.

E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective.

Origoni M, Cristoforoni P, Carminati G, Stefani C, Costa S, Sandri MT, Mariani L, Preti M.

Ecancermedicalscience. 2015 Apr 29;9:533. doi: 10.3332/ecancer.2015.533. eCollection 2015. Review.

37.

VIN usual type-from the past to the future.

Preti M, Igidbashian S, Costa S, Cristoforoni P, Mariani L, Origoni M, Sandri MT, Boveri S, Spolti N, Spinaci L, Sanvito F, Preti EP, Falasca A, Radici G, Micheletti L.

Ecancermedicalscience. 2015 Apr 29;9:531. doi: 10.3332/ecancer.2015.531. eCollection 2015. Review.

38.

Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.

Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P, Sandri MT.

Ecancermedicalscience. 2015 Apr 29;9:528. doi: 10.3332/ecancer.2015.528. eCollection 2015. Review.

39.

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.

Bottari F, Sideri M, Gulmini C, Igidbashian S, Tricca A, Casadio C, Carinelli S, Boveri S, Ejegod D, Bonde J, Sandri MT.

J Clin Microbiol. 2015 Jul;53(7):2109-14. doi: 10.1128/JCM.00246-15. Epub 2015 Apr 22.

40.

Molecular profiling of single circulating tumor cells with diagnostic intention.

Polzer B, Medoro G, Pasch S, Fontana F, Zorzino L, Pestka A, Andergassen U, Meier-Stiegen F, Czyz ZT, Alberter B, Treitschke S, Schamberger T, Sergio M, Bregola G, Doffini A, Gianni S, Calanca A, Signorini G, Bolognesi C, Hartmann A, Fasching PA, Sandri MT, Rack B, Fehm T, Giorgini G, Manaresi N, Klein CA.

EMBO Mol Med. 2014 Nov;6(11):1371-86. doi: 10.15252/emmm.201404033.

41.

Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer.

Bissolati M, Sandri MT, Burtulo G, Zorzino L, Balzano G, Braga M.

Tumour Biol. 2015 Feb;36(2):991-6. doi: 10.1007/s13277-014-2716-0. Epub 2014 Oct 16.

PMID:
25318603
42.

Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery.

Magni E, Botteri E, Ravenda PS, Cassatella MC, Bertani E, Chiappa A, Luca F, Zorzino L, Bianchi PP, Adamoli L, Sandri MT, Zampino MG.

Int J Colorectal Dis. 2014 Sep;29(9):1053-9. doi: 10.1007/s00384-014-1958-z. Epub 2014 Jul 10.

PMID:
25008360
43.

Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).

Ewer M, Gianni L, Pane F, Sandri MT, Steiner RK, Wojnowski L, Yeh ET, Carver JR, Lipshultz SE, Minotti G, Armstrong GT, Cardinale D, Colan SD, Darby SC, Force TL, Kremer LC, Lenihan DJ, Sallan SE, Sawyer DB, Suter TM, Swain SM, van Leeuwen FE.

Ecancermedicalscience. 2014 May 29;8:433. doi: 10.3332/ecancer.2014.433. eCollection 2014.

44.

Cardiac complications of chemotherapy: role of biomarkers.

Colombo A, Sandri MT, Salvatici M, Cipolla CM, Cardinale D.

Curr Treat Options Cardiovasc Med. 2014 Jun;16(6):313. doi: 10.1007/s11936-014-0313-6.

PMID:
24771223
45.

Performance of self-sampled HPV test in comparison with liquid based cytology.

Igidbashian S, Boveri S, Radice D, Casadio C, Spolti N, Sandri MT, Sideri M.

Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:72-6. doi: 10.1016/j.ejogrb.2014.03.028. Epub 2014 Apr 8.

PMID:
24768230
46.

TnI-Ultra assay measurements in cancer patients: comparison with the conventional assay and clinical implication.

Salvatici M, Cardinale D, Botteri E, Bagnardi V, Mauro C, Cassatella MC, Lentati P, Bottari F, Zorzino L, Passerini R, Cipolla CM, Sandri MT.

Scand J Clin Lab Invest. 2014 Aug;74(5):385-91. doi: 10.3109/00365513.2014.898325. Epub 2014 Apr 3.

PMID:
24693994
47.

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S.

Lancet Oncol. 2014 Apr;15(4):406-14. doi: 10.1016/S1470-2045(14)70069-5. Epub 2014 Mar 11.

PMID:
24636208
48.

An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requests.

Gion M, Franceschini R, Rosin C, Trevisiol C, Peloso L, Zappa M, Fabricio AS; Working Group on Tumour Markers of Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC).

Clin Chem Lab Med. 2014 Jun;52(6):889-97. doi: 10.1515/cclm-2013-0708.

PMID:
24501159
49.

Recovery and time to growth of isolates in blood culture bottles: comparison of BD Bactec Plus Aerobic/F and BD Bactec Plus Anaerobic/F bottles.

Passerini R, Cassatella MC, Salvatici M, Bottari F, Mauro C, Radice D, Sandri MT.

Scand J Infect Dis. 2014 Apr;46(4):288-93. doi: 10.3109/00365548.2013.876510. Epub 2014 Jan 27.

PMID:
24460080
50.

An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer Diagnosis.

Yahalom G, Weiss D, Novikov I, Bevers TB, Radvanyi LG, Liu M, Piura B, Iacobelli S, Sandri MT, Cassano E, Allweis TM, Bitterman A, Engelman P, Vence LM, Rosenberg MM.

Biomark Cancer. 2013 Nov 19;5:71-80. doi: 10.4137/BIC.S13236. eCollection 2013.

Supplemental Content

Loading ...
Support Center